China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

by · The Cerbat Gem

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the stock.

China Pharma Trading Down 3.7 %

Shares of CPHI stock opened at $0.24 on Friday. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.21. The company has a current ratio of 0.84, a quick ratio of 0.24 and a debt-to-equity ratio of 0.19. The stock’s fifty day simple moving average is $0.21 and its 200-day simple moving average is $0.27.

China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%. The business had revenue of $0.93 million for the quarter.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles